I
Ivana Mikolašević
Researcher at University of Rijeka
Publications - 144
Citations - 2171
Ivana Mikolašević is an academic researcher from University of Rijeka. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Fatty liver. The author has an hindex of 20, co-authored 133 publications receiving 1496 citations.
Papers
More filters
Journal ArticleDOI
Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
TL;DR: In this article, transient elastography (FibroScan® TE) with controlled attenuation parameter (CAP) has demonstrated good accuracy in quantifying the levels of liver steatosis and fibrosis in patients with NAFLD.
Journal ArticleDOI
Dyslipidemia in patients with chronic kidney disease: etiology and management.
TL;DR: Patients with chronic kidney disease, including those with end-stage renal disease, treated with dialysis, or renal transplant recipients have an increased risk for cardiovascular disease (CVD) morbidity and mortality, and many factors can influence post-transplant dyslipidemia including immunosuppressive agents.
Journal ArticleDOI
Vitamin D Deficiency: Consequence or Cause of Obesity?
TL;DR: Targeting lifestyle through healthy diet and exercise should be the first treatment option that will affect both obesity-related dysmetabolic state and vitamin D deficiency, killing two birds with one stone.
Journal ArticleDOI
The Role of Iron And Iron Overload in Chronic Liver Disease
Sandra Milić,Ivana Mikolašević,Lidija Orlić,Edita Devcic,Nada Starčević-Čizmarević,Davor Štimac,Miljenko Kapović,Smiljana Ristić +7 more
TL;DR: The liver plays a major role in iron homeostasis; thus, in patients with chronic liver disease, iron regulation may be disturbed and iron-induced cellular damage may be prevented by regulating the production of hePCidin or by administering hepcidin agonists.
Journal ArticleDOI
Nonalcoholic fatty liver disease - A multisystem disease?
Ivana Mikolašević,Sandra Milić,Tamara Turk Wensveen,Ivana Grgic,Ivan Jakopčić,Davor Štimac,Felix M. Wensveen,Lidija Orlić +7 more
TL;DR: In this paper, the effects of NAFLD extend beyond the liver and are negatively associated with a range of chronic diseases, most notably cardiovascular disease (CVD), diabetes mellitus type 2 (T2DM) and chronic kidney disease, as well as several other pathologies.